论文部分内容阅读
FDA批准Navelbine为研究用治疗新药美国FDA批准BurroughsWellcome公司的抗癌药Navelbine(Vinorelbin酒石酸盐注射液,皮埃尔-法博里国际医药公司(PierreFab-ra注册)为研究用治疗新药(tIND)。由...
FDA Approves Navelbine for Research New Drugs FDA Approves Navelbine (Vinorelbin Tartrate Injection, Pierre Fab-ra Register) for Investigational New Drugs (tIND) from BurroughsWellcome Company. by...